The Federal Circuit’s operations are impacted by the COVID-19 pandemic. Please visit our COVID-19 page for more information.

20-1723: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA [RULE 36 JUDGMENT], Nonprecedential

Opinions/Orders posted:

AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA [RULE 36 JUDGMENT](pdf)
Appeal Number: 20-1723
Origin: DCT
Nonprecedential

To see more opinions and orders, follow this link: Opinions and Orders.